Therefore, Zhang et al. demonstrated that significantly reduced or increased activities of the NF-kB signaling pathway were found in ccRCC cells following treatment with an ROS scavenger or stimulator, respectively, which was consistent with the changes in pSTAT3 signaling activity and G6PD expression. This evidence concerns the gene G6PD and nonpapillary renal cell carcinoma.